Acurx Pharmaceuticals announces up to $7.1M offering
Source: SeekingAlpha
2026-04-16 08:19:53 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
- Most and least shorted healthcare stocks with up to $2B market cap in March
- Acurx signals launch of pivotal recurrent CDI trial in H2 2026 while strengthening ibezapolstat pipeline
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Acurx Pharmaceuticals announces up to $7.1M offering
Acurx Pharmaceuticals Inc.
NASDAQ: ACXP
ACXP Trading
-5.88% G/L:
$1.68 Last:
45,927 Volume:
$1.77 Open:
ACXP Latest News
May 12, 2026 07:01:00 am
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
May 04, 2026 08:00:00 am
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
April 27, 2026 08:00:00 am
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
ACXP Stock Data
$5,246,237
2,029,733
5.06%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Staten Island
